Synapse - Works

Results (988)

A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease

Meeting Abstract

Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
Blood (2014)

Fulltext@MSK | Save

Efficacy and risk factors analysis of upfront autologous stem cell mobilization using plerixafor and granulocyte-colony stimulating factor (GCSF) in patients with multiple myeloma

Meeting Abstract

Ogunniyi, A.; Rodriguez, M.; Devlin, S. M.; Adel, N. G.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; Giralt, S. A.; more...
Blood (2014)

Fulltext@MSK | Save

A phase Ib dose escalation trial of SAR650984 (anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma

Meeting Abstract

Martin, T. G.; Baz, R.; Benson, D. M.; Lendvai, N.; Campana, F.; Charpentier, E.; Vij, R.
Blood (2014)

Fulltext@MSK | Save

Patterns of infectious morbidity in patients with Waldenstrom's macroglobulinaemia/lymphoplasmacytic lymphoma: A population-based study

Meeting Abstract

Lund, S. H.; Hultcrantz, M.; Goldin, L.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
Blood (2014)

Fulltext@MSK | Save

Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies

Meeting Abstract

Lesokhin, A. M.; Ansell, S. M.; Armand, P.; Scott, E. C.; Halwani, A.; Gutierrez, M.; Millenson, M. M.; Cohen, A. D.; Schuster, S. J.; Lebovic, D.; more...
Blood (2014)

Fulltext@MSK | Save

Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant

Meeting Abstract

Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
Blood (2014)

Fulltext@MSK | Save

Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study

Meeting Abstract

Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
Blood (2014)

Fulltext@MSK | Save

Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities

Meeting Abstract

Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; more...
Blood (2014)

Fulltext@MSK | Save

Series of hairy cell leukemia patients with co-existent plasma cell disorders

Meeting Abstract

Korde, N.; Mailankody, S.; Arons, E.; Braylan, R. C.; Raffeld, M.; Maestri, E.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Maric, I.; more...
Blood (2014)

Fulltext@MSK | Save

Biomarker proteasome levels predict response to combination therapy with carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients

Meeting Abstract

Korde, N.; Dosani, T.; Simakova, O.; Mailankody, S.; Costello, R.; Roschewski, M.; Yuan, C.; Stetler-Stevenson, M.; Figg, W. D.; Landgren, O.; more...
Blood (2014)

Fulltext@MSK | Save